JLE

Innovations & Thérapeutiques en Oncologie

MENU

Focal therapy for prostate cancer: who, when, where and how? Volume 5, issue 5, September-October 2019

Figures


  • Figure 1
Authors
1 Hôpital universitaire de Zurich
Service de radiothérapie
Rämistrasse 100
8091 Zurich
Suisse
2 Hôpital Édouard Herriot
Service d’urologie
5, place d’Arsonval
69437 Lyon cedex 03
France
* Tirés à part

Focal therapy for prostate cancer is an organ preservation strategy that has been developed in recent years and has gained popularity among the community. Increasing evidence is available and promising results in terms of efficacy and tolerance have been obtained, not only for low-risk but also for intermediate-risk prostate cancers.

Licence This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License